Applikon, Inc - - BioPharm International


Applikon, Inc

BioPharm International
Volume 18, Issue 12

Company Description

Applikon develops, manufactures and supplies bioreactor systems for R&D, pilot plant and production in cell culture and microbial fermentation from 7 mm – 5,000 liter capacities. Recent technology advancements include standard off-the-shelf Allen Bradley, Siemens and Delta V control packages with integrated fieldbus technology.

Applikon's innovative new products include:

  • 24 Bioreactor, a fermentation and cell culture system providing individual control and monitoring conditions.
  • AppliFlex, a single-use bioreactor for research as well as scale up and manufacturing. Provides professional control and easy validation.

For more information about Applikon, see our website at

Technical Services

In-house and field technical services are located throughout Europe and North America.


Applikon Biotechnology a privately owned Dutch company, headquartered in Schiedam,The Netherlands. Started in 1973, Applikon has grown from a small company supplying laboratory instrumentation to a dynamic worldwide enterprise capable of supplying a broad and diverse line of bioreactor systems. Applikon's global distributor network includes countries in North America, Europe, Asia, Australia and New Zealand.

Major Products and Services

  • Bioreactors
  • Autoclavable glass and stainless steel bioreactors for fermentation and cell culture ranging in size from 1 to 30 liters
  • Steam in place (SIP) stainless steel benchtop bioreactors ranging in size from 7 to 30 liters
  • Custom bioreactors available up to 5000 liters

  • Controllers
  • ADI 1010
  • Standard Allen Bradley (controls up to 4 units)
  • Standard Siemens (controls up to 4 units)

  • Bio Consoles
  • ADI 1025
  • BioConsole XL

  • Software
  • BioXpert 3

  • Sensors
  • pH Sensors
  • DO Sensors

  • BioSep Perfusion, an advanced acoustic cell retention device
  • BioMass, an online instrument for viable cell mass
  • -24 Bioreactor, a fermentation and cell culture system with single-use 24-reactor cassettes providing individual control and monitoring conditions
  • AppliFlex, a single-use bioreactor for research as well as scale up and manufacturing

West Coast: 1180 Chess Drive, Foster City, CA 94404
East Coast: 85 Franklin Rd., Ste 1B, Dover, NJ 07801

West Coast: 650.578.1396
East Coast: 973.361.5387

West Coast: 650.578.8836
East Coast: 973.361.3006




blog comments powered by Disqus



AbbVie/Shire Deal Officially Off
October 20, 2014
Amgen Sues Sanofi and Regeneron over Patent for mAb Targeting PCSK9
October 20, 2014
EMA Works to Speed Up Ebola Treatment
October 20, 2014
Lilly to Close Manufacturing Facility in Puerto Rico
October 17, 2014
BioReliance Introduces New Predictive Assays
October 17, 2014
Author Guidelines
Source: BioPharm International,
Click here